{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:46:56Z","timestamp":1791920816338,"version":"4.3.4"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/cco.0b013e328355e131","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T13:15:25Z","timestamp":1342703725000},"page":"506-516","source":"Crossref","is-referenced-by-count":134,"title":["HIV infection, aging, and immune function"],"prefix":"10.1097","volume":"24","author":[{"given":"Robert","family":"Dubrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11904-010-0041-9","article-title":"HIV and aging: time for a new paradigm.","volume":"7","author":"Justice","year":"2010","journal-title":"Curr HIVAIDS Rep"},{"key":"R2-8-20210128","first-page":"689","article-title":"HIV surveillance - United States, 1981-2008.","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","article-title":"Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.","volume":"47","author":"Effros","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.","volume":"52","author":"Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1002\/cncr.25530","article-title":"Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.","volume":"116","author":"Seaberg","year":"2010","journal-title":"Cancer"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","article-title":"HIV infection, immunodeficiency, viral replication, and the risk of cancer.","volume":"20","author":"Silverberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e3181b033ab","article-title":"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.","volume":"52","author":"Bedimo","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States.","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States.","volume":"170","author":"Simard","year":"2010","journal-title":"Arch Intern Med"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.","volume":"54","author":"Silverberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV as an independent risk factor for incident lung cancer.","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/QAI.0b013e3181f53783","article-title":"Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users.","volume":"55","author":"Shiels","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2407-11-272","article-title":"Lung cancer in HIV patients and their parents: a Danish cohort study.","volume":"11","author":"Engsig","year":"2011","journal-title":"BMC Cancer"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2009.25.6149","article-title":"HIV as a risk factor for lung cancer in women: data from the Womens Interagency HIV Study.","volume":"28","author":"Levine","year":"2010","journal-title":"J Clin Oncol"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States.","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","article-title":"Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.","volume":"117","author":"Simard","year":"2011","journal-title":"Cancer"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","article-title":"Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.","volume":"99","author":"Franceschi","year":"2008","journal-title":"Br J Cancer"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/QAD.0b013e3282f2705d","article-title":"Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.","volume":"22","author":"Polesel","year":"2008","journal-title":"AIDS"},{"key":"R24-8-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIVAIDS compared with immunosuppressed transplant recipients: a meta-analysis.","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/QAD.0b013e3283319184","article-title":"HIV infection and the risk of cancers with and without a known infectious cause.","volume":"23","author":"Silverberg","year":"2009","journal-title":"AIDS"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","article-title":"HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.","volume":"17","author":"De Vuyst","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ogc.2009.02.003","article-title":"The epidemiology of anal human papillomavirus and related neoplasia.","volume":"36","author":"Palefsky","year":"2009","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/JCM.01321-06","article-title":"Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and negative women.","volume":"44","author":"Fakhry","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"key":"R30-8-20210128","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315039","article-title":"Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposis sarcoma.","volume":"180","author":"OBrien","year":"1999","journal-title":"J Infect Dis"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.201009-058WR","article-title":"Cigarette smoking in the HIV-infected population.","volume":"8","author":"Rahmanian","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"R32-8-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/09540120601095734","article-title":"Estimating the impact of alcohol consumption on survival for HIV individuals.","volume":"19","author":"Braithwaite","year":"2007","journal-title":"AIDS Care"},{"key":"R33-8-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer.","volume":"29","author":"Vesely","year":"2011","journal-title":"Ann Rev Immunol"},{"key":"R35-8-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R36-8-20210128","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R37-8-20210128","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/jnci\/djr216","article-title":"Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.","volume":"103","author":"Pine","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R38-8-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences.","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R39-8-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/aid.2011.0213","article-title":"Immune activation in the pathogenesis of treated chronic hiv disease: a workshop summary.","volume":"28","author":"Plaeger","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R40-8-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease.","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIVAIDS Rep"},{"key":"R41-8-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging.","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"R42-8-20210128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2009.06.002","article-title":"The role of immunity in elderly cancer.","volume":"74","author":"Malaguarnera","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"R43-8-20210128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05370.x","article-title":"Potential role of immunosenescence in cancer development.","volume":"1197","author":"Fulop","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R44-8-20210128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/COH.0b013e32833ed6f4","article-title":"Biomarkers of immune dysfunction in HIV.","volume":"5","author":"Nixon","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R45-8-20210128","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"R46-8-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.","volume":"56","author":"Baker","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R48-8-20210128","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/595888","article-title":"Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.","volume":"48","author":"Robbins","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R49-8-20210128","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/QAD.0b013e32834640e6","article-title":"Old age and anticytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.","volume":"25","author":"Appay","year":"2011","journal-title":"AIDS"},{"key":"R50-8-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2011.03.079","article-title":"Premature senescence of T cells in long-term survivors of renal transplantation.","volume":"407","author":"Li","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"R51-8-20210128","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS.","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R52-8-20210128","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/fon.09.28","article-title":"Cancer risk in HIV-infected persons: influence of CD4() count.","volume":"5","author":"Clifford","year":"2009","journal-title":"Future Oncol"},{"key":"R53-8-20210128","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/605594","article-title":"Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.","volume":"49","author":"Bruyand","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R54-8-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000328032","article-title":"Incidence of non-AIDS-defining cancer in antiretroviral treatment-naive subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.","volume":"80","author":"Krishnan","year":"2011","journal-title":"Oncology"},{"key":"R55-8-20210128","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/651688","article-title":"Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.","volume":"50","author":"Prosperi","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R56-8-20210128","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1002\/cncr.25311","article-title":"Relationship between current level of immunodeficiency and nonacquired immunodeficiency syndrome-defining malignancies.","volume":"116","author":"Reekie","year":"2010","journal-title":"Cancer"},{"key":"R57-8-20210128","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/QAD.0b013e32832e9b78","article-title":"Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.","volume":"23","author":"Marin","year":"2009","journal-title":"AIDS"},{"key":"R58-8-20210128","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283112b77","article-title":"HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.","volume":"22","author":"Monforte","year":"2008","journal-title":"AIDS"},{"key":"R59-8-20210128","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1182\/blood-2010-08-301531","article-title":"HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4 T-cell lymphocytes.","volume":"117","author":"Bohlius","year":"2011","journal-title":"Blood"},{"key":"R60-8-20210128","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"R61-8-20210128","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","article-title":"Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.","volume":"22","author":"Clifford","year":"2008","journal-title":"AIDS"},{"key":"R62-8-20210128","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2011.02.017","article-title":"HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.","volume":"55","author":"Bruyand","year":"2011","journal-title":"J Hepatol"},{"key":"R63-8-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"key":"R64-8-20210128","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cir207","article-title":"Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.","volume":"52","author":"Kesselring","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R65-8-20210128","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with AIDS.","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R66-8-20210128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QAD.0b013e328331f6e2","article-title":"Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.","volume":"24","author":"Crum-Cianflone","year":"2010","journal-title":"AIDS"},{"key":"R67-8-20210128","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/656775","article-title":"Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States.","volume":"202","author":"Conley","year":"2010","journal-title":"J Infect Dis"},{"key":"R68-8-20210128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2005.03.4413","article-title":"Elevated incidence of lung cancer among HIV-infected individuals.","volume":"24","author":"Engels","year":"2006","journal-title":"J Clin Oncol"},{"key":"R69-8-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","article-title":"HIV infection is associated with an increased risk for lung cancer, independent of smoking.","volume":"45","author":"Kirk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R70-8-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/QAD.0b013e3280118fca","article-title":"Elevated risk of lung cancer among people with AIDS.","volume":"21","author":"Chaturvedi","year":"2007","journal-title":"AIDS"},{"key":"R71-8-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.2011.558","article-title":"Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.","volume":"106","author":"Clifford","year":"2012","journal-title":"Br J Cancer"},{"key":"R72-8-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0b013e3181eef4f7","article-title":"Pulmonary infections and risk of lung cancer among persons with AIDS.","volume":"55","author":"Shebl","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R73-8-20210128","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIVhepatitis C coinfection natural history and disease progression.","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"R74-8-20210128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIVHCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr HIVAIDS Rep"},{"key":"R75-8-20210128","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1002\/hep.22883","article-title":"Hepatitis B and human immunodeficiency virus coinfection.","volume":"49","author":"Thio","year":"2009","journal-title":"Hepatology"},{"key":"R76-8-20210128","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1200\/JCO.2006.05.7984","article-title":"Hepatocellular carcinoma and non-Hodgkins lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.","volume":"24","author":"McGinnis","year":"2006","journal-title":"J Clin Oncol"},{"key":"R77-8-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1572-0241.2005.40670.x","article-title":"The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.","volume":"100","author":"Kramer","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R79-8-20210128","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/652650","article-title":"Late presentation for human immunodeficiency virus care in the United States and Canada.","volume":"50","author":"Althoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R80-8-20210128","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0b013e32833f4b1b","article-title":"Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis.","volume":"24","author":"Marks","year":"2010","journal-title":"AIDS"},{"key":"R81-8-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/QAI.0b013e318222c0f9","article-title":"Responding to the National HIVAIDS Strategy-setting the research agenda.","volume":"57","author":"Morin","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R82-8-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","article-title":"Antiretroviral therapy and management of HIV infection.","volume":"376","author":"Volberding","year":"2010","journal-title":"Lancet"},{"key":"R83-8-20210128","first-page":"118","article-title":"Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.","volume":"17","author":"Deeks","year":"2009","journal-title":"Top HIV Med"},{"key":"R84-8-20210128","first-page":"53","article-title":"The use of HAART for biological tumour therapy.","volume":"11","author":"Monini","year":"2006","journal-title":"J HIV Ther"},{"key":"R85-8-20210128","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrc1479","article-title":"Antitumour effects of antiretroviral therapy.","volume":"4","author":"Monini","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R86-8-20210128","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1245\/ASO.2003.03.032","article-title":"Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.","volume":"10","author":"Brown","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R87-8-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-005-5156-0","article-title":"Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.","volume":"93","author":"Ji","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R88-8-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood-2004-09-3748","article-title":"Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.","volume":"106","author":"Kurokawa","year":"2005","journal-title":"Blood"},{"key":"R89-8-20210128","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2174\/138161207780249191","article-title":"Antitumor activity of nonnucleosidic reverse transcriptase inhibitors.","volume":"13","author":"Landriscina","year":"2007","journal-title":"Curr Pharm Des"},{"key":"R91-8-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/mutage\/gei019","article-title":"Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.","volume":"20","author":"Olivero","year":"2005","journal-title":"Mutagenesis"},{"key":"R92-8-20210128","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1086\/518797","article-title":"Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.","volume":"196","author":"Gulick","year":"2007","journal-title":"J Infect Dis"},{"key":"R93-8-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/QAI.0b013e3181aa13c7","article-title":"The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patients.","volume":"51","author":"Crum-Cianflone","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R94-8-20210128","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R95-8-20210128","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","article-title":"Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS"},{"key":"R96-8-20210128","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/652750","article-title":"Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.","volume":"201","author":"Kalayjian","year":"2010","journal-title":"J Infect Dis"},{"key":"R97-8-20210128","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","article-title":"Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer.","volume":"4","author":"Morris","year":"2011","journal-title":"Cancer Prev Res"},{"key":"R98-8-20210128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis.","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R99-8-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and nonsteroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e328355e131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:38:16Z","timestamp":1621885096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201209000-00008"}},"subtitle":["implications for cancer risk and prevention"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e328355e131","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}